FDA Approves Upadacitinib for Adult Patients With Giant Cell Arteritis

Source: Pharmacy Times articles

A 15-mg dose with a corticosteroid taper regimen was superior to placebo in sustained remission from week 12 to 52.
Read More

You must be logged in to post a comment.